• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Judy E. Garber, MD, MPH

Publications

  • Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, Silver B, Fisher DC, Marcus KJ, Mauch PM.Prospective Study of the Efficacy of Breast Magnetic Resonance Imaging and Mammographic Screening in Survivors of Hodgkin Lymphoma.J Clin Oncol. 2013 Apr 22.
    23610104
  • Rath MG, Masciari S, Gelman R, Miron A, Miron P, Foley K, Richardson AL, Krop IE, Verselis SJ, Dillon DA, Garber JE.Prevalence of germline TP53 mutations in HER2+ breast cancer patients.Breast Cancer Res Treat. 2013 Apr 12.
    23580068
  • Domchek SM, Bradbury A, Garber JE, Offit K, Robson ME.Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?.J Clin Oncol. 2013 Apr 1;31(10):1267-70.
    23460708
  • Patenaude AF, Tung N, Ryan PD, Ellisen LW, Hewitt L, Schneider KA, Tercyak KP, Aldridge J, Garber JE.Young adult daughters of BRCA1/2 positive mothers: What do they know about hereditary cancer and how much do they worry?.Psycho Oncology. 2013 Feb 18.
    23417902
  • Yurgelun MB, Mercado R, Rosenblatt M, Dandapani M, Kohlmann W, Conrad P, Blanco A, Shannon KM, Chung DC, Terdiman J, Gruber SB, Garber JE, Syngal S, Stoffel EM.Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome.Gynecol Oncol. 2012 Dec;127(3):544-51.
    22940489
  • Coopey SB, Mazzola E, Buckley JM, Sharko J, Belli AK, Kim EM, Polubriaginof F, Parmigiani G, Garber JE, Smith BL, Gadd MA, Specht MC, Guidi AJ, Roche CA, Hughes KS.The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.Breast Cancer Res Treat. 2012 Nov 2.
    23117858
  • Patenaude AF, Demarco TA, Peshkin BN, Valdimarsdottir H, Garber JE, Schneider KA, Hewitt L, Hamilton J, Tercyak KP.Talking to Children About Maternal BRCA1/2 Genetic Test Results: A Qualitative Study of Parental Perceptions and Advice.J Genet Couns. 2012 Oct 24.
    23093334
  • Tung N, Garber JE, Lincoln A, Domchek SM.Frequency of Triple-Negative Breast Cancer in BRCA1 Mutation Carriers: Comparison Between Common Ashkenazi Jewish and Other Mutations.J Clin Oncol. 2012 Oct 22.
    23091104
  • Mai PL, Malkin D, Garber JE, Schiffman JD, Weitzel JN, Strong LC, Wyss O, Locke L, Means V, Achatz MI, Hainaut P, Frebourg T, Evans DG, Bleiker E, Patenaude A, Schneider K, Wilfond B, Peters JA, Hwang PM, Ford J, Tabori U, Ognjanovic S, Dennis PA, Wentzensen IM, Greene MH, Fraumeni JF, Savage SA.Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium.Cancer Genet. 2012 Oct;205(10):479-87.
    22939227
  • Kaplan JS, Schnitt SJ, Collins LC, Wang Y, Garber JE, Montgomery K, West RB, Krag K, Fetten K, Lincoln A, Tung NM.Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers.Am J Surg Pathol. 2012 Oct;36(10):1483-8.
    22613997
  • Buckley JM, Coopey SB, Sharko J, Polubriaginof F, Drohan B, Belli AK, Kim EM, Garber JE, Smith BL, Gadd MA, Specht MC, Roche CA, Gudewicz TM, Hughes KS.The feasibility of using natural language processing to extract clinical information from breast pathology reports.J Pathol Inform. 2012;3:23.
    22934236
  • Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, , Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, Nathanson KL, Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Gronwald J, Huzarski T, Cybulski C, Byrski T, Osorio A, Cajal TR, Stavropoulou AV, Benítez J, Hamann U, , Rookus M, Aalfs CM, de Lange JL, Meijers-Heijboer HE, Oosterwijk JC, van Asperen CJ, Gómez García EB, Hoogerbrugge N, Jager A, van der Luijt RB, , Easton DF, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Izatt L, Eeles R, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Godwin AK, Pathak H, , Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S, Barjhoux L, Léoné M, Gauthier-Villars M, Caux-Moncoutier V, de Pauw A, Hardouin A, Berthet P, Dreyfus H, Ferrer SF, Collonge-Rame MA, Sokolowska J, Buys S, Daly M, Miron A, Terry MB, Chung W, John EM, Southey M, Goldgar D, Singer CF, Tea MK, Gschwantler-Kaulich D, Fink-Retter A, Hansen TV, Ejlertsen B, Johannsson OT, Offit K, Sarrel K, Gaudet MM, Vijai J, Robson M, Piedmonte MR, Andrews L, Cohn D, DeMars LR, DiSilvestro P, Rodriguez G, Toland AE, Montagna M, Agata S, Imyanitov E, Isaacs C, Janavicius R, Lazaro C, Blanco I, Ramus SJ, Sucheston L, Karlan BY, Gross J, Ganz PA, Beattie MS, Schmutzler RK, Wappenschmidt B, Meindl A, Arnold N, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Nevanlinna H, Aittomäki K, Simard J, , Spurdle AB, Beesley J, Chen X, Tomlinson GE, Weitzel J, Garber JE, Olopade OI, Rubinstein WS, Tung N, Blum JL, Narod SA, Brummel S, Gillen DL, Lindor N, Fredericksen Z, Pankratz VS, Couch FJ, Radice P, Peterlongo P, Greene MH, Loud JT, Mai PL, Andrulis IL, Glendon G, Ozcelik H, , Gerdes AM, Thomassen M, Jensen UB, Skytte AB, Caligo MA, Lee A, Chenevix-Trench G, Antoniou AC, Neuhausen SL, .A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1362-70.
    22729394
  • Martins FC, De S, Almendro V, Gönen M, Park SY, Blum JL, Herlihy W, Ethington G, Schnitt SJ, Tung N, Garber JE, Fetten K, Michor F, Polyak K.Evolutionary pathways in BRCA1-associated breast tumors.Cancer Discovery. 2012 Jun;2(6):503-11.
    22628410
  • Levy DE, Byfield SD, Comstock CB, Garber JE, Syngal S, Crown WH, Shields AE.Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk.Genet Med. 2011 Apr;13(4):349-355.
    21358336
  • Spurdle M, Marquart L, McGuffog L, Healey S, Sinilnikova OM, Wan F, Chen X, Beesley J, Singer CF, Dressler AC, Gschwantler-Kaulich D, Blum JL, Tung N, Weitzel JN, Lynch HT, Garber JE, Easton D, Peock S, Cook M, Oliver CT, Frost D, Conroy D, Evans DG, Lalloo F, Eeles RA, Izatt L, Davidson R, Chu C, Eccles D, Selkirk CG, Daly MB, Isaacs C, Stoppa-Lyonet D, Buecher B, Belotti M, Mazoyer S, Barjhoux L, Verny-Pierre C, Lasset C, Dreyfus H, Pujol P, Collonge-Rame MA, Collaborators GS, Rookus MA, Verhoef S, Kriege M, Hoogerbrugge N, Ausems MG, van Os TA, Wijnen JT, Devilee P, Meijers-Heijboer HE, Blok MJ, Heikkinen T, Nevanlinna HA, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Durocher F, Couch FJ, Lindor NM, Wang X, Thomasson M, Domchek SM, Nathanson KL, Caligo MA, Jernström HC, Liljegren A, Ehrencrona H, Karlsson P, Ganz PA, Olopade OI, Tomlinson G, Neuhausen SL, Antoniou AC, Chenevix-Trench G, Rebbeck TR.Common genetic variation at BARD1 is not associated with Breast cancer risk in BRCA1 or BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev. 2011 Mar 10.
    21393566
  • Polyak K, Garber J.Targeting the missing links for cancer therapy.Nat Med. 2011 Mar;17(3):283-4.
    21383736
  • Hofstatter EW, Domchek SM, Miron A, Garber J, Wang M, Componeschi K, Boghossian L, Miron PL, Nathanson KL, Tung N.PALB2 mutations in familial breast and pancreatic cancer.Fam Cancer. 2011 Mar 2.
    21365267
  • Lee LJ, Alexander B, Schnitt SJ, Comander A, Gallagher B, Garber JE, Tung N.Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers.Cancer. 2011 Jan 24.
    21264845
  • Issa JP, Garber JE.Time to think outside the (genetic) box.Cancer Prev Res (Phila Pa). 2011 Jan;4(1):6-8.
    21205738
  • Alexander BM, Sprott K, Farrow DA, Wang X, D'Andrea AD, Schnitt SJ, Collins LC, Weaver DT, Garber JE.DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer.Clin Cancer Res. 2010 Dec 1;16(23):5796-804.
    21138871
  • Tung N, Miron A, Schnitt SJ, Gautam S, Fetten K, Kaplan J, Yassin Y, Buraimoh A, Kim JY, Szasz AM, Tian R, Wang ZC, Collins LC, Brock J, Krag K, Legare RD, Sgroi D, Ryan PD, Silver D, Garber JE, Richardson AL.Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers.Breast Cancer Res. 2010 Nov 16;12(6):R95.
    21080930
  • Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, Macdonald DJ, Mahoney MC, Merajver SD, Meszoely I, Newman L, Pritchard E, Seewaldt V, Sellin RV, Shapiro CL, Ward JH.Breast cancer risk reduction.J Natl Compr Canc Netw. 2010 Nov;8(10):1112-46.
    20971838
  • Moorman PG, Iversen ES, Marcom PK, Marks JR, Wang F, , Lee E, Ursin G, Rebbeck TR, Domchek SM, Arun B, Susswein L, Isaacs C, Garber JE, Visvanathan K, Griffin CA, Sutphen R, Brzosowicz J, Gruber S, Finkelstein DM, Schildkraut JM.Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.Breast Cancer Res Treat. 2010 Nov;124(2):441-51.
    20309627
  • Domchek SM, Friebel TM, Garber JE, Isaacs C, Matloff E, Eeles R, Evans DG, Rubinstein W, Singer CF, Rubin S, Lynch HT, Daly MB, Weitzel J, Ganz PA, Pichert G, Olopade OI, Tomlinson G, Tung N, Blum JL, Couch F, Rebbeck TR.Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.Breast Cancer Res Treat. 2010 Nov;124(1):195-203.
    20180014
  • Joffe H, Partridge A, Giobbie-Hurder A, Li X, Habin K, Goss P, Winer E, Garber J.Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.Menopause.;17(5):908-16.
    20581724
  • Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van t'veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR.Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.JAMA. 2010 Sep 1;304(9):967-75.
    20810374
  • Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, Friedlander M, Arun B, Loman N, Schmutzler RK, Wardley A, Mitchell G, Earl H, Wickens M, Carmichael J.Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.Lancet. 2010 Jul 24;376(9737):235-44.
    20609467
  • Garber JE, Halabi S, Tolaney SM, Kaplan E, Archer L, Atkins JN, Edge S, Shapiro CL, Dressler L, Paskett ED, Paskett EM, Kimmick G, Orcutt J, Scalzo A, Winer E, Levine E, Shahab N, Berliner N, .Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.Journal of the National Cancer Institute. 2010 Jul 7;102(13):942-9.
    20554945
  • Daly MB, Axilbund JE, Buys S, Crawford B, Farrell CD, Friedman S, Garber JE, Goorha S, Gruber SB, Hampel H, Kaklamani V, Kohlmann W, Kurian A, Litton J, Marcom PK, Nussbaum R, Offit K, Pal T, Pasche B, Pilarski R, Reiser G, Shannon KM, Smith JR, Swisher E, Weitzel JN.Genetic/Familial high-risk assessment: breast and ovarian.J Natl Compr Canc Netw. 2010 May;8(5):562-94.
    20495085
  • Pierce LJ, Phillips KA, Griffith KA, Buys S, Gaffney DK, Moran MS, Haffty BG, Ben-David M, Kaufman B, Garber JE, Merajver SD, Balmaña J, Meirovitz A, Domchek SM.Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.Breast Cancer Res Treat. 2010 Jun;121(2):389-98.
    20411323
  • Ozanne EM, Wittenberg E, Garber JE, Weeks JC.Breast Cancer Prevention: Patient Decision Making and Risk Communication in the High Risk Setting.Breast J.;16(1):38-47.
    19889168
  • Tung N, Wang Y, Collins LC, Kaplan J, Li H, Gelman R, Comander AH, Gallagher B, Fetten K, Krag K, Stoeckert KA, Legare RD, Sgroi D, Ryan PD, Garber JE, Schnitt SJ.Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.Breast Cancer Res. 2010 Feb 11;12(1):R12.
    20149218
  • Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, Fatima A, Gelman RS, Ryan PD, Tung NM, De Nicolo A, Ganesan S, Miron A, Colin C, Sgroi DC, Ellisen LW, Winer EP, Garber JE.Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.J Clin Oncol. 2010 Mar 1;28(7):1145-53.
    20100965
  • Collins LC,Martyniak AJ,Kandel MJ,Stadler ZK,Masciari S,Miron A,Richardson AL,Schnitt SJ,Garber JE.Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers.Am J Surg Pathol. 2009 Jul;33(7):1093-7.
    19390427
  • Garber JE, Golshan M.Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side.J Clin Oncol. 2009 Dec 10;27(35):5862-4.
    19858367
  • Xian W, Miron A, Roh M, Semmel DR, Yassin Y, Garber J, Oliva E, Goodman A, Mehra K, Berkowitz RS, Crum CP, Quade BJ.The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube.J Pathol. 2010 Jan;220(1):17-23.
    19834951
  • Demarco TA, Nusbaum RH, Peshkin BN, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Tercyak KP.Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.Patient Educ Couns. 2010 Jan;78(1):29-33.
    19545972
  • Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Heerdt AS, Helvie M, Huff JG, Khakpour N, Khan SA, Krontiras H, Lyman G, Rafferty E, Shaw S, Smith ML, Tsangaris TN, Williams C, Yaneeklov T, .NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.J Natl Compr Canc Netw. 2009 Nov;7(10):1060-96. Review.
    19930975
  • Zhang J, Song YH, Brannigan BW, Wahrer DC, Schiripo TA, Harris PL, Haserlat SM, Ulkus LE, Shannon KM, Garber JE, Freedman ML, Henderson BE, Zou L, Sgroi DC, Haber DA, Bell DW.Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator Claspin.Mol Cancer Res. 2009 Sep;7(9):1510-6.
    19737971
  • De Nicolo A, Parisini E, Zhong Q, Dalla Palma M, Stoeckert KA, Domchek SM, Nathanson KL, Caligo MA, Vidal M, Cusick ME, Garber JE.Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del.Cancer Res. 2009 Sep 1;69(17):7030-7.
    19706752
  • Mueller J, Gazzoli I, Bandipalliam P, Garber JE, Syngal S, Kolodner RD.Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.Cancer Res. 2009 Sep 1;69(17):7053-61.
    19690142
  • Folkins AK, Saleemuddin A, Garrett LA, Garber JE, Muto MG, Tworoger SS, Crum CP.Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer.Gynecol Oncol. 2009 Oct;115(1):108-11.
    19615727
  • Rebbeck TR, Mitra N, Domchek SM, Wan F, Chuai S, Friebel TM, Panossian S, Spurdle A, Chenevix-Trench G, , Singer CF, Pfeiler G, Neuhausen SL, Lynch HT, Garber JE, Weitzel JN, Isaacs C, Couch F, Narod SA, Rubinstein WS, Tomlinson GE, Ganz PA, Olopade OI, Tung N, Blum JL, Greenberg R, Nathanson KL, Daly MB.Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.Cancer Res. 2009 Jul 15;69(14):5801-10.
    19584272
  • Peshkin BN, Demarco TA, Garber JE, Valdimarsdottir HB, Patenaude AF, Schneider KA, Schwartz MD, Tercyak KP.Brief Assessment of Parents' Attitudes Toward Testing Minor Children for Hereditary Breast/Ovarian Cancer Genes: Development and Validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).J Pediatr Psychol. 2009 Jul;34(6):627-38.
    18385162
  • Levy DE,Garber JE,Shields AE.Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization.J Gen Intern Med. 2009 Jul;24(7):822-8.
    19455369
  • Garber JE.BRCA1/2-associated and sporadic breast cancers: fellow travelers or not?.Cancer Prev Res (Phila Pa). 2009 Feb;2(2):100-3.
    19174575
  • Rainville I,Garber JE.Familial cancer database online.Lancet Oncol. 2008 Oct;9(10):925-6.
    19071253
  • Zon RT,Goss E,Vogel VG,Chlebowski RT,Jatoi I,Robson ME,Wollins DS,Garber JE,Brown P,Kramer BS.American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.J Clin Oncol. 2009 Feb 20;27(6):986-93.
    19075281
  • Burstein HJ,Chen YH,Parker LM,Savoie J,Younger J,Kuter I,Ryan PD,Garber JE,Chen H,Campos SM,Shulman LN,Harris LN,Gelman R,Winer EP.VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.Clin Cancer Res. 2008 Dec 1;14(23):7871-7.
    19047116
  • Keating NL,Stoeckert KA,Regan MM,DiGianni L,Garber JE.Physicians' experiences with BRCA1/2 testing in community settings.J Clin Oncol. 2008 Dec 10;26(35):5789-96.
    19001322
  • Saleemuddin A,Folkins AK,Garrett L,Garber J,Muto MG,Crum CP,Tworoger S.Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations.Gynecol Oncol. 2008 Nov;111(2):226-32.
    18718648
  • Patenaude AF,Orozco S,Li X,Kaelin CM,Gadd M,Matory Y,Mayzel K,Roche CA,Smith BL,Farkas W,Garber JE.Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy.Psychooncology. 2008 Aug;17(8):831-43.
    18636423
  • Masciari S, Van den Abbeele AD, Diller LR, Rastarhuyeva I, Yap J, Schneider K, Digianni L, Li FP, Fraumeni JF Jr, Syngal S, Garber JE.F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome.JAMA. 2008 Mar 19;299(11):1315-9.
    18349092
  • Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, Garber JE, Muto MG, Tworoger S, Crum CP.A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.Gynecol Oncol. 2008 May;109(2):168-73.
    18342932
  • Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, Friedman E, Narod S, Olshen AB, Gregersen P, Kosarin K, Olsh A, Bergeron J, Ellis NA, Klein RJ, Clark AG, Norton L, Dean M, Boyd J, Offit K.Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4340-5.
    18326623
  • Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR.Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.Clin Breast Cancer. 2007 Dec;7(11):875-82.
    18269778
  • Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, Neuhausen SL, Daly MB, Matloff E, Blum JL, Sabbatini P, Barakat RR, Hudis C, Norton L, Offit K, Rebbeck TR.Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.J Clin Oncol. 2008 Mar 10;26(8):1331-7.
    18268356
  • Wolff AC, Berry D, Carey LA, Colleoni M, Dowsett M, Ellis M, Garber JE, Mankoff D, Paik S, Pusztai L, Smith ML, Zujewski J.Research issues affecting preoperative systemic therapy for operable breast cancer.J Clin Oncol. 2008 Feb 10;26(5):806-13. Review.
    18258990
  • Offit K, Garber JE.Time to check CHEK2 in families with breast cancer?.J Clin Oncol. 2008 Feb 1;26(4):519-20.
    18172189
  • Gao B, Xie XJ, Huang C, Shames DS, Chen TT, Lewis CM, Bian A, Zhang B, Olopade OI, Garber JE, Euhus DM, Tomlinson GE, Minna JD.RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers.Cancer Res. 2008 Jan 1;68(1):22-5.
    18172292
  • Schrader KA, Masciari S, Boyd N, Wiyrick S, Kaurah P, Senz J, Burke W, Lynch HT, Garber JE, Huntsman DG.Hereditary diffuse gastric cancer: association with lobular breast cancer.Fam Cancer. 2008;7(1):73-82. Review.
    18046629
  • Antoniou AC, Sinilnikova OM, Simard J, Leone M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ, Rebbeck TR, Wagner T, Lynch HT, Domchek SM, Nathanson KL, Garber JE, Weitzel J, Narod SA, Tomlinson G, Olopade OI, Godwin A, Isaacs C, Jakubowska A, Lubinski J, Gronwald J, Gorski B, Byrski T, Huzarski T, Peock S, Cook M, Baynes C, Murray A, Rogers M, Daly PA, Dorkins H, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Niederacher D, Deissler H, Spurdle AB, Chen X, Waddell N, Cloonan N, Kirchhoff T, Offit K, Friedman E, Kaufmann B, Laitman Y, Galore G, Rennert G, Lejbkowicz F, Raskin L, Andrulis IL, Ilyushik E, Ozcelik H, Devilee P, Vreeswijk MP, Greene MH, Prindiville SA, Osorio A, Benitez J, Zikan M, Szabo CI, Kilpivaara O, Nevanlinna H, Hamann U, Durocher F, Arason A, Couch FJ, Easton DF, Chenevix-Trench G.RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.Am J Hum Genet. 2007 Dec;81(6):1186-200.
    17999359
  • Tercyak KP, Peshkin BN, Demarco TA, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Schwartz MD.Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.Genet Test. 2007 Fall;11(3):249-55.
    17949286
  • Segara D, Krop IE, Garber JE, Winer E, Harris L, Bellon JR, Birdwell R, Lester S, Lipsitz S, Iglehart JD, Golshan M.Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?.J Surg Oncol. 2007 Nov 1;96(6):474-80.
    17640031
  • Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Lawton T, Loftus L, Macdonald DJ, Mahoney MC, Merajver SD, Seewaldt V, Sellin RV, Shapiro CL, Singletary E, Ward JH.Breast cancer risk reduction.J Natl Compr Canc Netw. 2007 Sep;5(8):676-701.
    17927926
  • Javid SH, Carlson JW, Garber JE, Birdwell RL, Lester S, Lipsitz S, Golshan M.Breast MRI wire-guided excisional biopsy: specimen size as compared to mammogram wire-guided excisional biopsy and implications for use.Ann Surg Oncol. 2007 Dec;14(12):3352-8.
    17849165
  • Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, Feltmate CM, Berkowitz RS, Muto MG.Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.J Clin Oncol. 2007 Sep 1;25(25):3985-90.
    17761984
  • Bell DW, Kim SH, Godwin AK, Schiripo TA, Harris PL, Haserlat SM, Wahrer DC, Haiman CA, Daly MB, Niendorf KB, Smith MR, Sgroi DC, Garber JE, Olopade OI, Le Marchand L, Henderson BE, Altshuler D, Haber DA, Freedman ML.Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.Int J Cancer. 2007 Dec 15;121(12):2661-7.
    17721994
  • Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K.Molecular definition of breast tumor heterogeneity.Cancer Cell. 2007 Mar;11(3):259-73.
    17349583
  • Li Y, Pan J, Li JL, Lee JH, Tunkey C, Saraf K, Garbe JC, Whitley MZ, Jelinsky SA, Stampfer MR, Haney SA.Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized.Mol Cancer. 2007;6:7.
    17233903
  • Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP.A candidate precursor to serous carcinoma that originates in the distal fallopian tube.J Pathol. 2007 Jan;211(1):26-35.
    17117391
  • Schneider KA, Chittenden AB, Branda KJ, Keenan MA, Joffe S, Patenaude AF, Reynolds H, Dent K, Eubanks S, Goldman J, Leroy B, Warren NS, Taylor K, Vockley CW, Garber JE.Ethical issues in cancer genetics: I 1) whose information is it?.J Genet Couns. 2006 Dec;15(6):491-503.
    17106632
  • Abramson N, Costantino JP, Garber JE, Berliner N, Wickerham DL, Wolmark N.Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.J Natl Cancer Inst. 2006 Jul 5;98(13):904-10.
    16818854
  • Carlson RW, Moench SJ, Hammond ME, Perez EA, Burstein HJ, Allred DC, Vogel CL, Goldstein LJ, Somlo G, Gradishar WJ, Hudis CA, Jahanzeb M, Stark A, Wolff AC, Press MF, Winer EP, Paik S, Ljung BM,.HER2 testing in breast cancer: NCCN Task Force report and recommendations.J Natl Compr Canc Netw. 2006 Jul;4 Suppl 3:S1-22; quiz S23-4. Review.
    16813731
  • Burstein HJ, Mayer E, Patridge AH, O'Kane H, Litsas G, Come SE, Hudis CA, Goldstein DF, Muss HB, Winter EP, Garber JE.Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.Clin Breast Cancer. 2006 Jun;7(2):158-61.
    16800976
  • Golshan M, Miron A, Nixon AJ, Garber JE, Cash EP, Iglehart JD, Harris JR, Wong JS.The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.Am J Surg. 2006 Jul;192(1):58-62.
    16769276
  • , Ganz PA, Kwan L, Somerfield MR, Alberts D, Garber JE, Offit K, Lippman SM.The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members.J Clin Oncol. 2006 Jun 20;24(18):2948-57.
    16702579
  • Bevers TB, Anderson BO, Bonaccio E, Borgen PI, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Helvie M, Hoover S, Krontiras H, Shaw S, Singletary E, Sugg Skinner C, Smith ML, Tsangaris TN, Wiley EL, Williams C.Breast cancer screening and diagnosis.J Natl Compr Canc Netw. 2006 May;4(5):480-508.
    16687096
  • Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, Harris EE, Gaffney DK, Haffty BG, Dawson LA, Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, Isaacs C, Merajver SD, Wong JS, Garber JE, Weber BL.Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.J Clin Oncol. 2006 Jun 1;24(16):2437-43.
    16636335
  • Smolen GA, Muir B, Mohapatra G, Barmettler A, Kim WJ, Rivera MN, Haserlat SM, Okimoto RA, Kwak E, Dahiya S, Garber JE, Bell DW, Sgroi DC, Chin L, Deng CX, Haber DA.Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.Cancer Res. 2006 Apr 1;66(7):3452-5.
    16585167
  • Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, Foulkes WD, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchrist D, Eng C, Offit K, Osborne M, Sun P, Narod SA.Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.Breast Cancer Res. 2006;8(2):R15.
    16563180
  • Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson GE, Van't Veer L, Lynch HT, Olopade OI, Weber BL, Rebbeck TR.Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Lancet Oncol. 2006 Mar;7(3):223-9.
    16510331
  • Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN,.Genetic/familial high-risk assessment: breast and ovarian.J Natl Compr Canc Netw. 2006 Feb;4(2):156-76.
    16451772
  • Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE.Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.J Clin Oncol. 2006 Feb 1;24(4):700-6.
    16446344
  • Digianni LM, Rue M, Emmons K, Garber JE.Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations.Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):70-5.
    16434589
  • Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW, Crum CP.The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.Am J Surg Pathol. 2006 Feb;30(2):230-6.
    16434898
  • Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, Wong J, Gelman R, Bunnell CA, Parker LM, Garber JE, Winer EP, Harris JR, Powell SN.Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast cancer.Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):496-504.
    16243442
  • Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH, Li FP, Syngal S.Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.Gastroenterology. 2006 Jan;130(1):73-9.
    16401470
  • Larson PS, Schlechter BL, de las Morenas A, Garber JE, Cupples LA, Rosenberg CL.Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues.J Clin Oncol. 2005 Dec 1;23(34):8613-9.
    16314623
  • Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR.The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.Carcinogenesis. 2006 Mar;27(3):599-605.
    16244359
  • Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS, Hodin R, Heitritter S, Moore F, Dluhy R, Sosa JA, Ocal IT, Benn DE, Marsh DJ, Robinson BG, Schneider K, Garber J, Arum SM, Korbonits M, Grossman A, Pigny P, Toledo SP, Nose V, Li C, Stiles CD.A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.PLoS Genet. 2005 Jul;1(1):72-80.
    16103922
  • Kurian AW, Mills MA, Jaffee M, Sigal BM, Chun NM, Kingham KE, Collins LC, Nowels KW, Plevritis SK, Garber JE, Ford JM, Hartman AR.Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk.Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1082-9.
    15894656
  • Li FP, Fletcher JA, Heinrich MC, Garber JE, Sallan SE, Curiel-Lewandrowski C, Duensing A, van de Rijn M, Schnipper LE, Demetri GD.Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.J Clin Oncol. 2005 Apr 20;23(12):2735-43.
    15837988
  • Schneider KA, DiGianni LM, Patenaude AF, Klar N, Stopfer JE, Calzone KA, Li FP, Weber BL, Garber JE.Accuracy of cancer family histories: comparison of two breast cancer syndromes.Genet Test. 2004 Fall;8(3):222-8.
    15727243
  • Garber JE, Offit K.Hereditary cancer predisposition syndromes.J Clin Oncol. 2005 Jan 10;23(2):276-92.
    15637391
  • Balmaa J, Stoffel EM, Emmons KM, Garber JE, Syngal S.Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes.J Med Genet. 2004 Apr;41(4):e44.
    15060120
  • Garber JE, Hartman AR.Prophylactic oophorectomy and hormone replacement therapy: protection at what price?.J Clin Oncol. 2004 Mar 15;22(6):978-80.
    14981100
  • Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL.Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.J Clin Oncol. 2004 Mar 15;22(6):1055-62.
    14981104
  • Garber JE.Breast cancer screening: a final analysis?.CA Cancer J Clin. 2003 May-Jun;53(3):138-40.
    12809407
  • Leibowitz SB, Garber JE, Fox EA, Loda M, Kaufman DS, Kantoff PW, Oh WK.Male patients with diagnoses of both breast cancer and prostate cancer.Breast J. 2003 May-Jun;9(3):208-12.
    12752629
  • Stoffel EM, Garber JE, Grover S, Russo L, Johnson J, Syngal S.Cancer surveillance is often inadequate in people at high risk for colorectal cancer.J Med Genet. 2003 May;40(5):e54.
    12746408
  • Cannistra SA, Bast RC, Berek JS, Bookman MA, Crum CP, DePriest PD, Garber JE, Koh WJ, Markman M, McGuire WP, Rose PG, Rowinsky EK, Rustin GJ, Skates SJ, Vasey PA, King L.Progress in the management of gynecologic cancer: consensus summary statement.J Clin Oncol. 2003 May 15;21(10 Suppl):129-32.
    12743127
  • DiGianni LM, Kim HT, Emmons K, Gelman R, Kalkbrenner KJ, Garber JE.Complementary medicine use among women enrolled in a genetic testing program.Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):321-6.
    12692106
  • Narod SA, Dube MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE, Neuhausen SL, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F, Foulkes WD, Warner E, Kim-Sing C, Olopade O, Tung N, Saal HM, Weitzel J, Merajver S, Gauthier-Villars M, Jernstrom H, Sun P, Brunet JS.Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.J Natl Cancer Inst. 2002 Dec 4;94(23):1773-9.
    12464649
  • Chen WY, Garber JE, Higham S, Schneider KA, Davis KB, Deffenbaugh AM, Frank TS, Gelman RS, Li FP.BRCA1/2 genetic testing in the community setting.J Clin Oncol. 2002 Nov 15;20(22):4485-92.
    12431973
  • Lehmann LS, Weeks JC, Klar N, Garber JE.A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.Genet Med. 2002 Sep-Oct;4(5):346-52.
    12394347
  • Gazzoli I, Loda M, Garber J, Syngal S, Kolodner RD.A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor.Cancer Res. 2002 Jul 15;62(14):3925-8.
    12124320
  • Wahlberg SS, Schmeits J, Thomas G, Loda M, Garber J, Syngal S, Kolodner RD, Fox E.Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.Cancer Res. 2002 Jun 15;62(12):3485-92.
    12067992
  • Euhus DM, Smith KC, Robinson L, Stucky A, Olopade OI, Cummings S, Garber JE, Chittenden A, Mills GB, Rieger P, Esserman L, Crawford B, Hughes KS, Roche CA, Ganz PA, Seldon J, Fabian CJ, Klemp J, Tomlinson G.Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.J Natl Cancer Inst. 2002 Jun 5;94(11):844-51.
    12048272
  • Berry DA, Iversen ES, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G.BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.J Clin Oncol. 2002 Jun 1;20(11):2701-12.
    12039933
  • Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL,.Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.N Engl J Med. 2002 May 23;346(21):1616-22.
    12023993
  • Diller L, Medeiros Nancarrow C, Shaffer K, Matulonis U, Mauch P, Neuberg D, Tarbell NJ, Litman H, Garber J.Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study.J Clin Oncol. 2002 Apr 15;20(8):2085-91.
    11956269
  • Lee SB, Kim SH, Bell DW, Wahrer DC, Schiripo TA, Jorczak MM, Sgroi DC, Garber JE, Li FP, Nichols KE, Varley JM, Godwin AK, Shannon KM, Harlow E, Haber DA.Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.Cancer Res. 2001 Nov 15;61(22):8062-7.
    11719428
  • Ang P, Garber JE.Genetic susceptibility for breast cancer--risk assessment and counseling.Semin Oncol. 2001 Aug;28(4):419-33.
    11498834
  • Rebbeck TR, Wang Y, Kantoff PW, Krithivas K, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Brunet JS, Vesprini D, Garber JE, Lynch HT, Weber BL, Brown M.Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.Cancer Res. 2001 Jul 15;61(14):5420-4.
    11454686
  • Nichols KE, Malkin D, Garber JE, Fraumeni JF, Li FP.Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):83-7.
    11219776
  • Seth P, Lunetta KL, Bell DW, Gray H, Nasser SM, Rhei E, Kaelin CM, Iglehart DJ, Marks JR, Garber JE, Haber DA, Polyak K.Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.Cancer Res. 2000 Dec 15;60(24):6859-63.
    11156380
  • Lehmann LS, Weeks JC, Klar N, Biener L, Garber JE.Disclosure of familial genetic information: perceptions of the duty to inform.Am J Med. 2000 Dec 15;109(9):705-11.
    11137485
  • Lu KH, Garber JE, Cramer DW, Welch WR, Niloff J, Schrag D, Berkowitz RS, Muto MG.Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.J Clin Oncol. 2000 Jul;18(14):2728-32.
    10894872
  • Burstein HJ, Manola J, Younger J, Parker LM, Bunnell CA, Scheib R, Matulonis UA, Garber JE, Clarke KD, Shulman LN, Winer EP.Docetaxel administered on a weekly basis for metastatic breast cancer.J Clin Oncol. 2000 Mar;18(6):1212-9.
    10715290
  • Emmons KM, Kalkbrenner KJ, Klar N, Light T, Schneider KA, Garber JE.Behavioral risk factors among women presenting for genetic testing.Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):89-94.
    10667468
  • Schrag D, Kuntz KM, Garber JE, Weeks JC.Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.JAMA. 2000 Feb 2;283(5):617-24.
    10665701
  • Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE, Haber DA.Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.Science. 1999 Dec 24;286(5449):2528-31.
    10617473
  • Kolodner RD, Tytell JD, Schmeits JL, Kane MF, Gupta RD, Weger J, Wahlberg S, Fox EA, Peel D, Ziogas A, Garber JE, Syngal S, Anton-Culver H, Li FP.Germ-line msh6 mutations in colorectal cancer families.Cancer Res. 1999 Oct 15;59(20):5068-74.
    10537275
  • Syngal S, Fox EA, Li C, Dovidio M, Eng C, Kolodner RD, Garber JE.Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing.JAMA. 1999 Jul 21;282(3):247-53.
    10422993
  • Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M.Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.Am J Hum Genet. 1999 May;64(5):1371-7.
    10205268
  • Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM.Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.Ann Intern Med. 1998 Nov 15;129(10):787-96.
    9841584
  • Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS.Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.Clin Cancer Res. 1995 May;1(5):539-44.
    9816013
  • Chabner E, Nixon A, Gelman R, Hetelekidis S, Recht A, Bornstein B, Connolly J, Schnitt S, Silver B, Manola J, Harris J, Garber J.Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer.J Clin Oncol. 1998 Jun;16(6):2045-51.
    9626202
  • Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, Weber BL, Lenoir GM, Lynch HT, Narod SA.Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes.J Natl Cancer Inst. 1998 May 20;90(10):761-6.
    9605646
  • Hisada M, Garber JE, Fung CY, Fraumeni JF, Li FP.Multiple primary cancers in families with Li-Fraumeni syndrome.J Natl Cancer Inst. 1998 Apr 15;90(8):606-11.
    9554443
  • Foretova L, Garber JE, Sadowsky NL, Verselis SJ, Joseph DM, Andrade AF, Gudrais PG, Fairclough D, Li FP.Carcinoembryonic antigen in breast nipple aspirate fluid.Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):195-8.
    9521431
  • Schrag D, Kuntz KM, Garber JE, Weeks JC.Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.N Engl J Med. 1997 May 15;336(20):1465-71.
    9148160
  • Rubin SC, Benjamin I, Behbakht K, Takahashi H, Morgan MA, LiVolsi VA, Berchuck A, Muto MG, Garber JE, Weber BL, Lynch HT, Boyd J.Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1.N Engl J Med. 1996 Nov 7;335(19):1413-6.
    8875917
  • Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Garber JE, et al.Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.Nat Med. 1996 Nov;2(11):1179-83.
    8898735
  • Rebbeck TR, Couch FJ, Kant J, Calzone K, DeShano M, Peng Y, Chen K, Garber JE, Weber BL.Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.Am J Hum Genet. 1996 Sep;59(3):547-53.
    8751855
  • FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA.Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.N Engl J Med. 1996 Jan 18;334(3):143-9.
    8531968
  • Biesecker BB, Boehnke M, Calzone K, Markel DS, Garber JE, Collins FS, Weber BL.Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.JAMA. 1993 Apr 21;269(15):1970-4.
    8352830
  • Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF, Li FP.Follow-up study of twenty-four families with Li-Fraumeni syndrome.Cancer Res. 1991 Nov 15;51(22):6094-7.
    1933872
  • Garber JE, Burke EM, Lavally BL, Billett AL, Sallan SE, Scott RM, Kupsky W, Li FP.Choroid plexus tumors in the breast cancer-sarcoma syndrome.Cancer. 1990 Dec 15;66(12):2658-60.
    2249207